These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6752297)

  • 1. Enocin: an antibiotic produced by Streptococcus salivarius that may contribute to protection against infections due to group A streptococci.
    Sanders CC; Sanders WE
    J Infect Dis; 1982 Nov; 146(5):683-90. PubMed ID: 6752297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
    Tagg JR
    Indian J Med Res; 2004 May; 119 Suppl():13-6. PubMed ID: 15232154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial interference. IV. Epidemiological determinants of the antagonistic activity of the normal throat flora against group A streptococci.
    Sanders CC; Nelson GE; Sanders WE
    Infect Immun; 1977 May; 16(2):599-603. PubMed ID: 324915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.
    Wescombe PA; Upton M; Dierksen KP; Ragland NL; Sivabalan S; Wirawan RE; Inglis MA; Moore CJ; Walker GV; Chilcott CN; Jenkinson HF; Tagg JR
    Appl Environ Microbiol; 2006 Feb; 72(2):1459-66. PubMed ID: 16461700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The streptococcal inhibitor of complement (SIC) protects Streptococcus pyogenes from bacteriocin-like inhibitory substance (BLIS) from Streptococcus salivarius.
    Minami M; Ohmori D; Tatsuno I; Isaka M; Kawamura Y; Ohta M; Hasegawa T
    FEMS Microbiol Lett; 2009 Sep; 298(1):67-73. PubMed ID: 19594623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory substances produced by Streptococcus salivarius and colonization of the upper respiratory tract with group A streptococci.
    Huskins WC; Kaplan EL
    Epidemiol Infect; 1989 Jun; 102(3):401-12. PubMed ID: 2500355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of normal oral flora, particularly group oral streptococci as defense mechanism against infection in healthy individuals (normal defense mechanism by oral Streptococcus group)].
    Fujimori I; Yamada T; Kikushima K; Goto R; Ogino J; Hisamatsu K; Murakami Y
    Kansenshogaku Zasshi; 1992 Dec; 66(12):1634-8. PubMed ID: 1294668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference by an alpha-hemolytic streptococcus of beta-hemolytic pathogenic streptococci.
    Beck A
    Inflammation; 1979 Sep; 3(4):463-5. PubMed ID: 389799
    [No Abstract]   [Full Text] [Related]  

  • 9. Probiotics Streptococcus salivarius 24SMB and Streptococcus oralis 89a interfere with biofilm formation of pathogens of the upper respiratory tract.
    Bidossi A; De Grandi R; Toscano M; Bottagisio M; De Vecchi E; Gelardi M; Drago L
    BMC Infect Dis; 2018 Dec; 18(1):653. PubMed ID: 30545317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro studies of growth and competition between S. salivarius TOVE-R and mutans streptococci.
    Kurasz AB; Tanzer JM; Bazer L; Savoldi E
    J Dent Res; 1986 Sep; 65(9):1149-53. PubMed ID: 3461031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics.
    Wescombe PA; Heng NC; Burton JP; Chilcott CN; Tagg JR
    Future Microbiol; 2009 Sep; 4(7):819-35. PubMed ID: 19722837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The production of bacteriocin-like substances by the oral bacterium Streptococcus salivarius.
    Dempster RP; Tagg JR
    Arch Oral Biol; 1982; 27(2):151-7. PubMed ID: 7044350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of normal oropharyngeal flora in the development of streptococcal pharyngitis and outcome of penicillin therapy].
    Mihajlović-Ukropina M; Roncević N
    Med Pregl; 1998; 51(5-6):275-8. PubMed ID: 9720358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius.
    Wescombe PA; Upton M; Renault P; Wirawan RE; Power D; Burton JP; Chilcott CN; Tagg JR
    Microbiology (Reading); 2011 May; 157(Pt 5):1290-1299. PubMed ID: 21310787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults.
    Di Pierro F; Adami T; Rapacioli G; Giardini N; Streitberger C
    Expert Opin Biol Ther; 2013 Mar; 13(3):339-43. PubMed ID: 23286823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriocin production by Streptococcus salivarius strain P.
    Tagg JR; Russell C
    Can J Microbiol; 1981 Sep; 27(9):918-23. PubMed ID: 7306880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomics of Streptococcus salivarius, a major human commensal.
    Delorme C; Abraham AL; Renault P; Guédon E
    Infect Genet Evol; 2015 Jul; 33():381-92. PubMed ID: 25311532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtilin-antibiotic produced by Bacillus subtilis; effect on Streptococcus pyogenes infections in mice.
    SALLE AJ; JANN GJ
    Proc Soc Exp Biol Med; 1946 Dec; 63(3):519. PubMed ID: 20281096
    [No Abstract]   [Full Text] [Related]  

  • 19. The occurrence of nucleases in culture filtrates of group A hemolytic streptococci.
    McCARTY M
    J Exp Med; 1948 Aug; 88(2):181-8. PubMed ID: 18873867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and properties of an extracellular bacteriocin from Streptococcus mutans bacteriocidal for group A and other streptococci.
    Paul D; Slade HD
    Infect Immun; 1975 Dec; 12(6):1375-85. PubMed ID: 1107225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.